Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the percutaneous nephrolithotomy market grown over the years?

In recent times, there has been a substantial increase in the size of the percutaneous nephrolithotomy market. A strong growth trajectory has been observed, with projections of it increasing from $17.9 billion in 2024 to $19.54 billion in 2025, registering a compound annual growth rate (CAGR) of 9.1%. Factors instrumental in this growth during the historical period include a rise in the occurrence of kidney stones, burgeoning requirement for effective and efficient kidney stone treatments, healthcare infrastructure developments in growing economies, an aging population which signals a higher occurrence of kidney stones, escalation in research and development undertakings, increased health care spending, and a rising focus on patient-centric healthcare.

What Is the forecasted market size and growth rate for the percutaneous nephrolithotomy market?

The market size for percutaneous nephrolithotomy is set to witness significant growth in the upcoming years, with a predicted value of $27.36 billion in 2029 and an 8.8% compound annual growth rate (CAGR). This growth in the forecasted period can be linked to the increasing popularity of minimally invasive surgical practices, a surge in demand for efficient stone removal procedures, escalating consciousness about percutaneous nephrolithotomy benefits, increasing elderly population vulnerable to kidney stone development, extended availability of sophisticated medical technologies for stone removal, heightened focus on patient-oriented care, and a notable rise in preference for outpatient surgeries. The anticipated trends during this period consist of the use of miniaturized instruments, imaging technology advancements, the introduction of robotics, the popularity of disposable tools, improvements in stone retrieval devices, progress in anesthesia techniques, the implementation of robust infection prevention measures, the execution of multimodal pain management approaches, and the establishment of comprehensive training programs.

Get your percutaneous nephrolithotomy market report here!

https://www.thebusinessresearchcompany.com/report/percutaneous-nephrolithotomy-global-market-report

What are the major factors driving growth in the percutaneous nephrolithotomy market?

The escalating number of renal disease cases is predicted to fuel the expansion of the percutaneous nephrolithotomy market. Renal diseases are a variety of conditions impeding the kidneys’ optimal functioning. The increasing occurrence of such diseases is attributed to higher diabetes and hypertension incidences, an ageing demographic, unhealthy lifestyle habits, inherent genetics, chronic ailments, along with better awareness and diagnosis. The use of percutaneous nephrolithotomy helps in the management of renal diseases, offering a minimally invasive surgery to excise sizeable or complicated kidney stones, ease pain, thwart urinary tract infections, and enhance kidney function. For example, as of June 2023, Kidney Research Commission, established in the UK and managed by ZS Associates, indicated that kidney disease impacted 7.19 million UK citizens in 2023—a figure predicted to increase to 7.61 million by the year 2033. Thus, the escalating incidence of renal diseases is propelling the percutaneous nephrolithotomy market. A significant driver of the Percutaneous Nephrolithotomy (PCNL) market is the burgeoning demand for minimally invasive surgeries. Medical procedures that require body entrance, typically through incisions, for treatment or diagnosis purposes are delineated as invasive surgeries. The swelling uptake for minimally invasive surgeries (MIS) can be attributed to discernable benefits, including reduced recovery duration and hospitalization, decreased complications risk, less pain and scarring, in addition to improved accuracy owing to advanced tech. The effectiveness of minimally invasive surgeries is hugely beneficial for the PCNL procedures, given the less invasive modus operandi in treating kidney stones. As per an account published by Intuitive Surgical Inc., a robotic products producer based in the US, there were nearly 1,875,000 surgeries executed using Vinci Surgical Systems in 2022, an impressive 18% upsurge compared to the about 1,594,000 surgeries done with Vinci Surgical Systems the previous year, 2021. Consequently, the rising adoption rate for minimally invasive surgeries is responsible for the percutaneous nephrolithotomy market’s growth.

What key areas define the segmentation of the global percutaneous nephrolithotomy Market?

The percutaneous nephrolithotomy market covered in this report is segmented –

1) By Type: Magnesium Ammonium Phosphate Stone Type, Calcareous Type, Uric Acid Calculi Type

2) By Component: Accessories, Devices, Services

3) By End-User: Ambulatory Surgical Centers, Clinics, Hospitals

Subsegments:

1) By Magnesium Ammonium Phosphate Stone Type: Struvite Stones, Triple Phosphate Stones

2) By Calcareous Type: Calcium Oxalate Stones, Calcium Phosphate Stones

3) By Uric Acid Calculi Type: Primary Uric Acid Stones, Secondary Uric Acid Stones

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16506&type=smp

What are the top market players propelling the growth of the percutaneous nephrolithotomy industry?

Major companies operating in the percutaneous nephrolithotomy market are Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Coloplast Corporation, B. Braun, Cook Medical, Teleflex Incorporated, Karl Storz Se And Co. KG, Merit Medical Systems, Richard Wolf GmbH, AngioDynamics, Argon Medical Devices, Dornier MedTech, EDAP TMS, Allengers Medical Systems Limited, DirexGroup, Envaste Limited, ELMED Lithotripsy Systems, PolyDiagnost, Attikouris Enterprises Ltd., Advin Urology, Avenda Health, Guangzhou Potent Optotronic Technology Co. Ltd., Surgimedik

How are evolving market trends shaping percutaneous nephrolithotomy Strategies?

Companies that are significant players in the percutaneous nephrolithotomy market are emphasizing on adopting progressive solutions like robot-assisted surgical platforms to increase surgical accuracy and patient results. These platforms are sophisticated medical systems that employ robotics technology to provide surgeons with heightened precision, control, and flexibility during complex surgeries. For instance, in February 2023, Ethicon Inc., a MedTech company owned by US-based Johnson & Johnson, announced the successful extraction of kidney stones with the aid of a robotic-assisted surgery on its first patient through the MONARCH Platform designed for urology. This platform facilitates the navigation within the kidney by urologists using robotic help specifically designed for accessibility, clearance, and control through a handheld device. It offers a solo platform that supports both ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, delivering enhanced navigation, accessibility, clearance, and control in comparison to conventional methods.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16506

What regions are dominating the percutaneous nephrolithotomy market growth?

North America was the largest region in the percutaneous nephrolithotomy market in 2024. The regions covered in the percutaneous nephrolithotomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Injection Molded Plastics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injection-molded-plastics-global-market-report

Nephrologists Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/nephrologists-market

Nephrology Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: